Advanced search×

Guided self-help treatment for recurrent binge eating: replication and extension.

Lynn L Debar, Ruth H Striegel-Moore, G Terence Wilson, Nancy Perrin, Bobbi Jo Yarborough, John Dickerson, Frances Lynch, Francine Rosselli, and Helena C Kraemer

Psychiatr Serv 62(4):367-73 (2011) PMID 21459987

The aim of this study was to replicate and extend results of a previous blended efficacy and effectiveness trial of a low-intensity, manual-based guided self-help form of cognitive-behavioral therapy (CBT-GSH) for the treatment of binge eating disorders in a large health maintenance organization (HMO) and to compare them with usual care.

DOI: 10.1176/appi.ps.62.4.367
Version: za2963e q8zaf q8zb8 q8zc6 q8zd8 q8zec q8zf0 q8zgb
Buy PDF

Similar articles you may find interesting…

  1. A systematic review of randomised control trials assessing mesh fixation in open inguinal hernia repair.
    D L Sanders and S Waydia

    Hernia (2013) PMID 23649403

    There is insufficient evidence to promote fibrin sealant, self-fixing meshes or NB2C glues ahead of suture fixation. However, these products have been shown to be at least substantially equivalent, and moderate-quality RCTs have suggested that both fibrin sealant and NB2C glues may have a beneficial...
    Buy PDF
  2. Older adults are mobile too! Identifying the barriers and facilitators to older adults' use of mHealth for pain management.
    Samantha J Parker, Sonal Jessel, and M Cary Reid

    BMC Geriatr 13(1):43 (2013) PMID 23647949

    This study suggests that older adults with CP are interested and willing to use mHealth to assist in the management of pain. Participants in our study reported important barriers that medical professionals, researchers, and mHealth developers should address to help facilitate the development and eva...
    PDF not found
  3. Canakinumab: A Guide to Its Use in Acute Gouty Arthritis Flares.
    Katherine A Lyseng-Williamson

    BioDrugs (2013) PMID 23649936

    Canakinumab (Ilaris(®)), an anti-interleukin-1β monoclonal antibody, is a novel approach to treat acute gouty arthritis flares in a targeted population of patients in whom treatment options are limited. Relative to on-demand treatment with intramuscular triamcinolone acetonide 40 ...
    Buy PDF